Brendan Smith

Insider Reports History

Entity
Individual
Location
29 Hartwell Avenue, Lexington, MA
Signature
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brendan Smith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Chief Financial Officer Common Shares 5.07K $317K $62.50 Feb 21, 2023 Direct
CRISPR Therapeutics AG Chief Financial Officer Restricted Stock Units 11.5K Feb 18, 2023 Direct
Translate Bio, Inc. Chief Financial Officer Stcok Option (right to buy) 0 Sep 14, 2021 Direct

Insider Reports Filed by Brendan Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRSP CRISPR Therapeutics AG Feb 18, 2023 3 -$67.2K 4 Feb 22, 2023 Chief Financial Officer
CRSP CRISPR Therapeutics AG Oct 14, 2022 3 -$61.9K 4 Oct 18, 2022 Chief Financial Officer
CRSP CRISPR Therapeutics AG Oct 7, 2022 1 $0 4 Oct 12, 2022 Chief Financial Officer
CRSP CRISPR Therapeutics AG Aug 16, 2022 1 $0 4 Aug 18, 2022 Chief Financial Officer
CRSP CRISPR Therapeutics AG Feb 18, 2022 2 $0 4 Feb 22, 2022 Chief Financial Officer
CRSP CRISPR Therapeutics AG Oct 14, 2021 2 $0 4 Oct 18, 2021 Chief Financial Officer
CRSP CRISPR Therapeutics AG Oct 14, 2021 0 $0 3 Oct 15, 2021 Chief Financial Officer
TBIO Translate Bio, Inc. Sep 14, 2021 1 $0 4 Sep 14, 2021 Chief Financial Officer